Abstract:Bacteriophages, the most abundant organisms on earth, have the potential to address the rise of multidrug-resistant bacteria resulting from the overuse of antibiotics. However, their high specificity and limited host range can hinder their effectiveness. Phage engineering, through the use of gene editing techniques, offers a means to enhance the host range of bacteria, improve phage efficacy, and facilitate efficient cell-free production of phage drugs. To engineer phages effectively, it is necessary to understand the interaction between phages and host bacteria. Understanding the interaction between the receptor recognition protein of bacteriophages and host receptors can serve as a valuable guide for modifying or replacing these proteins, thereby altering the receptor range of the bacteriophage. Research and development focused on the CRISPR-Cas bacterial immune system against bacteriophage nucleic acids can provide the necessary tools to promote recombination and counter-selection in engineered bacteriophage programs. Additionally, studying the transcription and assembly functions of bacteriophages in host bacteria can facilitate the engineered assembly of bacteriophage genomes in non-host environments. This review highlights a comprehensive summary of phage engineering methods, including in-host and out-of-host engineering, and the use of high-throughput methods to understand their role. The main aim of these techniques is to harness the intricate interactions between bacteriophages and hosts to inform and guide the engineering of bacteriophages, particularly in the context of studying and manipulating the host range of bacteriophages. By employing advanced high-throughput methods to identify specific bacteriophage receptor recognition genes, and subsequently introducing modifications or performing gene swapping through in-host recombination or out-of-host synthesis, it becomes possible to strategically alter the host range of bacteriophages. This capability holds immense significance for leveraging bacteriophages as a promising therapeutic approach against antibiotic-resistant bacteria.

Bacteriophage P22 SieA-mediated superinfection exclusion

Phage against the Machine: The SIE-ence of Superinfection Exclusion

Prophages block cell surface receptors to ensure survival of their viral progeny

Filamentous Prophage Capsid Proteins Contribute to Superinfection Exclusion and Phage Defence in Pseudomonas Aeruginosa

Single nucleotide switches confer bacteriophage resistance to Pseudomonas protegens

A Filamentous Bacteriophage Protein Inhibits Type IV Pili To Prevent Superinfection of Pseudomonas aeruginosa

Inducible Prophage Mutant of Escherichia Coli Can Lyse New Host and the Key Sites of Receptor Recognition Identification

Sub-therapeutic Concentrations of Antibiotics Induce Prophage-driven Superinfection Exclusion and Fitness Cost in Pseudomonas aeruginosa

Bacteriophage Isolation, Purification, and Characterization Techniques Against Ubiquitous Opportunistic Pathogens

Putative pseudolysogeny-dependent phage gene implicated in the superinfection resistance of Cutibacterium acnes

Bacteria vs. Bacteriophages: Parallel Evolution of Immune Arsenals.

Bacterium secretes chemical inhibitor that sensitizes competitor to bacteriophage infection

Visualizing Infection Initiation of Bacteriophage P22 by Cryo-Electron Tomography

Engineering bacteriophages for enhanced host range and efficacy: insights from bacteriophage-bacteria interactions

Breakdown and exclusion of superinfecting T-even bacteriophage in Escherichia coli

Structural dynamics of bacteriophage P22 infection initiation revealed by cryo-electron tomography

A phage-encoded counter-defense inhibits an NAD-degrading anti-phage defense system

Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection

Pf4 Phage Variant Infection Reduces Virulence-Associated Traits in Pseudomonas aeruginosa

Genomic and biological insights of bacteriophages JNUWH1 and JNUWD in the arms race against bacterial resistance

A Bacterial Dynamin-Like Protein Confers a Novel Phage Resistance Strategy on the Population Level in Bacillus subtilis